India’s gene-sequencing consortia has classified the new Delta plus mutation of coronavirus as a variant of concern, following 22 cases being reported across three states including Maharashtra, Kerala and Madhya Pradesh.
The Delta plus variant, Indian SARS-CoV-2 Genomic Consortia (INSACOG) said, has increased transmissibility, stronger binding to receptors of lung cells and has the potential to reduce response to monoclonal antibody treatment.
INSACOG is a consortium of 28 laboratories of Ministry of Health & Family Welfare, Dept. of Biotechnology, Indian Council of Medical Research (ICMR) and Council of Scientific and Industrial Research (CSIR) for whole genome sequencing in the context